JP2005505565A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505565A5
JP2005505565A5 JP2003526933A JP2003526933A JP2005505565A5 JP 2005505565 A5 JP2005505565 A5 JP 2005505565A5 JP 2003526933 A JP2003526933 A JP 2003526933A JP 2003526933 A JP2003526933 A JP 2003526933A JP 2005505565 A5 JP2005505565 A5 JP 2005505565A5
Authority
JP
Japan
Prior art keywords
group
substituted
acyl
benzyl
protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003526933A
Other languages
English (en)
Japanese (ja)
Other versions
JP4688414B2 (ja
JP2005505565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2002/001228 external-priority patent/WO2003022860A1/en
Publication of JP2005505565A publication Critical patent/JP2005505565A/ja
Publication of JP2005505565A5 publication Critical patent/JP2005505565A5/ja
Application granted granted Critical
Publication of JP4688414B2 publication Critical patent/JP4688414B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003526933A 2001-09-07 2002-09-06 合成ヘパリン五糖 Expired - Fee Related JP4688414B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR758701 2001-09-07
AUPR7587 2001-09-07
PCT/AU2002/001228 WO2003022860A1 (en) 2001-09-07 2002-09-06 Synthetic heparin pentasaccharides

Publications (3)

Publication Number Publication Date
JP2005505565A JP2005505565A (ja) 2005-02-24
JP2005505565A5 true JP2005505565A5 (enExample) 2006-03-16
JP4688414B2 JP4688414B2 (ja) 2011-05-25

Family

ID=34437858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526933A Expired - Fee Related JP4688414B2 (ja) 2001-09-07 2002-09-06 合成ヘパリン五糖

Country Status (10)

Country Link
US (5) US7541445B2 (enExample)
EP (2) EP2557086A3 (enExample)
JP (1) JP4688414B2 (enExample)
CN (1) CN1558911B (enExample)
AU (1) AU2002331426B2 (enExample)
CA (4) CA2806561C (enExample)
DK (1) DK1440077T3 (enExample)
ES (1) ES2423888T3 (enExample)
PT (1) PT1440077E (enExample)
WO (1) WO2003022860A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541445B2 (en) 2001-09-07 2009-06-02 Alchemia Limited Synthetic heparin pentasaccharides
AU2002950657A0 (en) * 2002-08-08 2002-09-12 Alchemia Limited Derivatives of monosaccharides for drug discovery
JP2006143694A (ja) * 2004-11-16 2006-06-08 Tokyo Kasei Kogyo Kk 新規p−メトキシフェニル糖誘導体
ES2336297B1 (es) * 2008-10-08 2011-01-24 Laboratorios Farmaceuticos Rovi, S.A. Procedimiento de sintesis de pentasacaridos desprotegidos a partir deun pentasacarido precursos protegido.
CA2757091A1 (en) 2009-03-30 2010-10-14 University Of Georgia Research Foundation, Inc. Heparan sulfate synthesis
EP3666786A1 (en) * 2009-07-31 2020-06-17 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2512448B1 (en) * 2009-12-18 2016-07-06 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide
EP2683746A4 (en) * 2011-03-10 2014-09-03 Callaghan Innovation Res Ltd oligosaccharide
US20130005954A1 (en) * 2011-06-28 2013-01-03 Apicore, Llc Process for preparing heparinoids and intermediates useful in the synthesis thereof
CN103360439B (zh) * 2012-04-02 2017-12-15 浙江海正药业股份有限公司 制备肝素五糖的新中间体及其制备方法
JP6138241B2 (ja) * 2012-05-25 2017-05-31 ツェジャン ハイサン ファーマシューティカル カンパニー リミテッド 完全に保護されたヘパリン五糖類およびその中間体を調製するための方法
CN102690302B (zh) * 2012-05-30 2015-07-01 济南圣泉唐和唐生物科技有限公司 1,2-O-异亚丙基-3-O-苄基-α-D-呋喃葡萄糖苷的制备方法
CN102718808A (zh) * 2012-06-04 2012-10-10 浙江星月药物科技股份有限公司 一类多糖衍生物及其中间体的制备方法
CN104619712B (zh) * 2012-06-05 2017-09-12 中央研究院 制备磺达肝素的方法和中间体
CN102775450B (zh) * 2012-07-03 2015-04-08 华东师范大学 一种1,6-脱水-2-叠氮-2-脱氧-β-D-吡喃葡萄糖的制备方法
CN102898487B (zh) * 2012-11-13 2016-03-09 麦科罗夫(南通)生物制药有限公司 一种磺达肝葵钠二糖中间体片段ba及其合成方法
CN102942601B (zh) * 2012-11-30 2015-09-30 江苏华泰晨光药业有限公司 一种磺达肝癸钠的中间体的制备方法
WO2014205115A2 (en) 2013-06-19 2014-12-24 The Regents Of The University Of California Regioselective silyl exchange of per-silylated oligosaccharides
EP3024840B1 (en) * 2013-07-25 2019-10-02 ScinoPharm Taiwan, Ltd. Process for the production of fondaparinux sodium
WO2015011517A1 (en) * 2013-07-25 2015-01-29 Scinopharm Taiwan, Ltd. Process for the production of fondaparinux sodium
US10072039B2 (en) * 2013-07-25 2018-09-11 Scinopharm Taiwan, Ltd. Process for the production of Fondaparinux sodium
US9346844B2 (en) 2013-07-25 2016-05-24 Scinopharm Taiwan, Ltd. Process for the production of fondaparinux sodium
CN103601765B (zh) * 2013-09-02 2017-01-04 上海艾康睿医药科技有限公司 磺达肝癸钠及其中间体、以及制备方法
JP2016537349A (ja) 2013-11-14 2016-12-01 浙江海正薬業股▲ふん▼有限公司Zhejiang Hisun Pharmaceutical CO.,LTD. 二糖中間体及びその合成方法
CN104098618A (zh) * 2014-07-25 2014-10-15 河北常山生化药业股份有限公司 磺达肝癸钠中间体及其中间体和磺达肝癸钠的制备方法
WO2016040779A1 (en) * 2014-09-12 2016-03-17 The Board Of Trustees Of The University Of Illinois Urea derivatives of polyene macrolide antibiotics
US9909534B2 (en) 2014-09-22 2018-03-06 Ini Power Systems, Inc. Carbureted engine having an adjustable fuel to air ratio
CN105985388A (zh) * 2015-02-04 2016-10-05 苏州朗科生物技术有限公司 磺达肝癸钠杂质化合物及其制备方法和应用
CN105985387A (zh) * 2015-02-04 2016-10-05 苏州朗科生物技术有限公司 一种磺达肝癸钠杂质化合物及其制备方法和用途
CN104910217B (zh) * 2015-06-19 2018-04-17 天津红日药业股份有限公司 用于磺达肝癸钠质量控制的参比化合物
CN104876979B (zh) * 2015-06-19 2018-10-09 天津红日药业股份有限公司 一种具有抗Xa因子活性的磺酸化五糖化合物
US10023603B2 (en) * 2015-07-16 2018-07-17 Formosa Laboratories, Inc. Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids
CN106518935B (zh) * 2016-10-26 2019-05-21 陕西国防工业职业技术学院 一种3,6-二去氧-3-氨基-l-艾杜糖及其衍生物的合成方法
CN107501359B (zh) * 2017-08-24 2020-07-31 深圳市海滨制药有限公司 一种磺达肝癸钠杂质化合物及其制备方法与应用
US11306157B2 (en) 2018-12-21 2022-04-19 California Institute Of Technology Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly
CN109734757B (zh) * 2019-03-11 2020-09-11 淮北师范大学 一种磺达肝癸钠注射液有关物质b的制备方法
WO2021043631A1 (en) 2019-09-02 2021-03-11 Hepoligo Solutions Aps Intermediates useful for preparing iduronic acid containing di- and polysaccharides
WO2021083735A1 (en) 2019-10-29 2021-05-06 Hepoligo Solutions Aps Process for the production of 1,6-anhydro sugars
CN110746471B (zh) * 2019-11-04 2021-06-25 江苏美迪克化学品有限公司 一种磺达肝癸钠双糖中间体的制备方法
EP4247826A1 (en) * 2020-11-19 2023-09-27 Indian Institute Of Science Education And Research Silver assisted gold catalysis for the preparation of fondaparinux pentasaccharide and intermediates
CN112552359B (zh) * 2020-12-21 2022-11-25 北京大学 一种磺达肝葵钠五糖中间体自动化制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US187381A (en) * 1877-02-13 Improvement in air and steasvj blowers for furnaces
US13862A (en) * 1855-12-04 Cutting pile fabrics
US684691A (en) 1901-03-23 1901-10-15 Donald E Webster Micrometer-gage.
IL61201A (en) 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
FR2504535B1 (fr) * 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
FR2519987A1 (fr) * 1982-01-15 1983-07-22 Choay Sa Trisaccharides a structures d-glucosamine, acide d-glucuronique, d-glucosamine et leur preparation
FR2531436A1 (fr) * 1982-08-06 1984-02-10 Choay Sa Pentasaccharides substitues possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
CA1247608A (fr) * 1981-12-23 1988-12-28 Jean Choay Derives a structure acide uronique, leur preparation et leurs applications biologiques
FR2518550A1 (fr) * 1981-12-23 1983-06-24 Choay Sa Procede de preparation de monosaccharides a structure acide l-iduronique
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な5糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
JPH03237101A (ja) * 1989-12-18 1991-10-23 Rikagaku Kenkyusho グリコシルフォスファチジルイノシトールアンカー合成中間体及びグリコシルフォスファチジルイノシトールアンカー類縁体の合成中間体
JPH0616692A (ja) * 1992-07-03 1994-01-25 Nisshin Oil Mills Ltd:The 新規糖誘導体
CA2100821C (en) * 1993-07-19 2001-01-16 Stephen Hanessian Stereocontrolled glycosidation
JP3837876B2 (ja) * 1996-11-05 2006-10-25 和光純薬工業株式会社 アジドハロゲノベンジル誘導体及び水酸基の保護方法
JP3005669B2 (ja) 1996-12-19 2000-01-31 工業技術院長 不斉な含フッ素一級アミンの製造法
US6538117B1 (en) * 1999-08-10 2003-03-25 The Scripps Research Institute Programmable one-pot oligosaccharide synthesis
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
CA2435637A1 (en) * 2001-01-23 2002-08-01 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
US7541445B2 (en) 2001-09-07 2009-06-02 Alchemia Limited Synthetic heparin pentasaccharides

Similar Documents

Publication Publication Date Title
JP2005505565A5 (enExample)
EP1692126B1 (de) Reaktive cyclische carbonate und harnstoffe zur modifizierung von biomolekülen, polymeren und oberflächen
FI77870B (fi) Foerfarande foer framstaellning av antivirala difluorsubstituerade nukleosider och difluorkolhydrater anvaendbara som mellanprodukter vid foerfarandet.
US6342590B1 (en) Erythromycin a derivatives and method for preparing same
WO2004078813A3 (en) Process for the manufacture of blocked mercaptosilanes
JP2005532287A5 (enExample)
JP2002522446A5 (enExample)
CA2492775A1 (en) Polyalkylene glycol acid additives
AU7868400A (en) Neutral-cationic lipid for nucleic acid and drug delivery
JP2004529172A5 (enExample)
US4613666A (en) Neplanocin A derivatives
KR840005733A (ko) 무라밀 펩타이드의 제조방법
EP0713873A3 (en) Aminocyclopentane derivative
CN1278261A (zh) 新型喜树碱衍生物
JP2008503582A5 (enExample)
WO1998008854B1 (en) Sugar derivatives as sialyl lewis x mimetics
KR950703536A (ko) 치환된 이미다졸 화합물의 유용한 중간체를 제조하는 방법(process of synthesizing useful intermediates of substituted imidazole compounds)
ATE183224T1 (de) Wässrige beschichtungszusammensetzungen
WO1984004749A1 (en) Novel preparation of nucleoside phosphoramidite intermediates
JP2625620B2 (ja) フコシル‐グルコサミン誘導体
US5621086A (en) Sialic acid derivative and method of manufacturing it
GB1494663A (en) O-triazolyl(thiono)-phosphoric(phosphonic)acid esters and ester-amides process for their preparation and their use as insecticides acaricides or nematocides
WO2008077799A3 (en) Compounds and methods for amino-alkylenediol synthesis
JP2008540362A5 (enExample)
JP2812981B2 (ja) ジサッカライド誘導体の中間体及びその製造法